ZENA:NASDAQZenaTech, Inc. Analysis
Data as of 2026-08-08 - not real-time
$1.65
Latest Price
9/10Risk
Risk Level: High
Executive Summary
ZenaTech, Inc. is priced at $1.65 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has gained 17.9%. Momentum indicators put RSI at 65.0 (approaching overbought) with MACD reading bullish. The recent range runs from support at $1.22 up to resistance at $1.75.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 172.5% above the current price. Revenue is growing at 639.9%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 82.2%, a beta of 2.24 and a maximum drawdown of 81.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 172.5% above the current price. Revenue is growing at 639.9%.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 82.2%, a beta of 2.24 and a maximum drawdown of 81.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
Drone as a Service enters into a global oil and gas drone inspection services market growing at 28% per year as Company...Derived from first quarter results of CAD $8.HUD Secretary Scott Turner acknowledged tribes need flexibility as they work to build more housing.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 2.60
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 2.60
- Analyst targets imply +172.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +172.5% versus the current price
- Negative return on equity of -132.0%
- Revenue growth of +639.9%
Key Metrics & Analysis
Financial Health
Revenue Growth639.90%
P/E Ratio-3.6
ROE-131.96%
ROA-37.17%
Debt/Equity19.61
P/B Ratio-46.2
Op. Cash Flow$-49393572
Free Cash Flow$-56532908
Industry P/E36.1
Technical Analysis
TrendBearish
RSI65.0
Support$1.22
Resistance$1.75
MA 20$1.41
MA 50$1.43
MA 200$2.60
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82
Valuation
Target Price$4.50
Upside/Downside172.46%
GradeFair
TypeGrowth
Risk Assessment
Beta2.24
Volatility82.22%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.